Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protokinetix Inc (OP:PKTX)

0.0083 +0.0031 (+59.62%)
Streaming Delayed Price Updated: 12:12 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Protokinetix Inc

News headline image
Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
From ProtoKinetix, Incorporated
Via Business Wire
News headline image
Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration
From ProtoKinetix, Incorporated
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.